News
CAMBRIDGE, Mass., September 26, 2024--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will webcast its upcoming TTR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback